Optimization of the Salmonella/mammalian microsome assay for urine mutagenesis by experimental designs

Mutation Research - Reviews in Genetic Toxicology

Volumn 340, Issue 2-3, 1996, Pages 51-65

  De Meo M ^a   Laget, M ^a   Di Giorgio, C ^a   Guiraud, H ^a   Botta, A ^a   Castegnaro, M ^b   Dumenil G ^a  

^a Lab de Biogenotoxicologie et M   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Experimental design; Salmonella mutagenicity test; Salmonella mammalian microsome assay; Urine mutagenicity

Indexed keywords

BENZO[A]PYRENE;

AMES TEST; ARTICLE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIUM CULTURE; MUTAGEN TESTING; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; URINALYSIS;

BACTERIA (MICROORGANISMS); MAMMALIA; SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0029313914     PISSN: 01651110     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0165-1110(96)90039-1     Document Type: Article

References (49)

1. Aeschbacher H.U., Finot P.A., Wolleb U. Interaction of histidine containing test substances and extraction methods with the Ames mutagenicity test. Mutation Res. 113:1983;103-106.
2. Agurell E., Stensman C. Salmonella mutagenicity of three complex mixtures assayed with the microsuspension technique. A WHO/IPCS/CSCM study. Mutation Res. 276:1992;87-91.
3. Anderson J.G., Calla D.R., Bryant D.W., Carny B.E., Brombe A.M. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay. Mutagenesis. 2:1987;279-285.
4. Andrews A.W., Thibault L.H., Lijinsky W. The relationship between carcinogenicity and mutagenicity of some polycyclic hydrocarbons. Mutation Res. 51:1978;311-318.
5. Ashby J. The prospects for a simplified and internationally harmonised approach to the detection of possible human carcinogens and mutagens. Mutagenesis. 1:1986;3-7.
6. Bartsch H., Camus A.M., Malaveille C. Comparative mutagenicity of N-nitrosamines in a semi-solid and liquid incubation system in the presence of rat or human tissue fractions. Mutation Res. 37:1976;149-162.
7. k-p fractional design. Technometrics. 3:1961;311-351.
8. Callander R.D. Observed convergence of the Salmonella plate and the preincubation assays when employing varying levels of S9. Mutagenesis. 1:1986;439-443.
9. Cayzac R., Carvette E. Parametric aerodynamic design of spinning finned projectiles using a matrix interpolation method. J. Space. Rock. 29:1992;51-56.
10. Claxton L.D., Douglas G., Krewski D., Lewtas J., Matsushita H., Rosenkranz H. Overview, conclusions and recommendations of the IPCS collaborative study on complex mixtures. Mutation Res. 276:1992;61-80.
11. Claxton L.D., Houk V.S., Allison J.C., Creason J. Evaluating the relationship of metabolic activation system concentrations and chemical dose concentrations for the Salmonella spiral and plate assay. Mutation Res. 253:1991;127-136.
12. De Méo M., Laget M., Castegnaro M., Duménil G. Genotoxic activity of potassium permanganate in acidic solutions. Mutation Res. 260:1991;295-306.
13. De Méo M., Miribel V., Botta A., Laget M., Duménil G. Applicability of the SOS Chromotest to detect urinary mutagenicity caused by smoking. Mutagenesis. 3:1988;277-283.
14. De Méo M., Vanelle P., Bernadini E., Laget M., Maldonado J., Jentzer O., Crozet M.P., Duménil G. Evaluation of the mutagenic and genotoxic activities of 48 nitroimidazole derivatives and related compounds by the Ames test and the SOS Chromotest. Env. Mol. Mutagenesis. 19:1992;167-181.
15. Doehlert D.H. Uniform shell designs. Appl. Stat. 19:1970;231-239.
16. Falck K., Gröhn P., Sousa M., Vainio H., Heinonen E., Holsti L.R. Mutagenicity in urine of nurses handling cytostatic drugs. Lancet. i:1979;1250-1252.
17. Gatehouse D.G., Wedd D.J. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests. Carcinogenesis. 5:1984;391-397.
18. Gatehouse D.G., Wedd D., Wharton K. The comparative mutagenicity of 4-dimethylaminoazobenzene and 4-cyanodimethylaniline in the plate incorporation test and fluctuation assay. Parry J.M., Arlett C.F. Comparative Genetic Toxicology. 1985;181-189 McMillan, Basingstoke.
19. Green M.H.L., Bridges B.A., Rogers A.M., Horspool G., Muriel W.J., Bridges J.W., Fry J.R. Mutagen screening by a simplified bacterial fluctuation test: use of microsomal preparations and whole liver cells for metabolic activation. Mutation Res. 48:1977;287-294.
20. Green M.H.L., Muriel W.J., Bridges B.A. Use of a simplified fluctuation test to detect low levels of mutagens. Mutation Res. 38:1976;33-42.
21. Gibson J.F., Boxer P.J., Hedworth-Whitty R.B., Gompertz D. Urine mutagenicity assays: a problem arising from the presence of histidine associated growth factors in XAD-2 prepared urine concentrates with particular relevance to assays carrying out using the bacterial fluctuation test. Carcinogenesis. 4:1983;1471-1476.
22. Gletten F., Weeks V., Brunick D. In vitro metabolic activation of chemical mutagens. I. Development of an in vitro mutagenic assay using liver microsomal enzymes for the activation of dimethylnitrosamine to a mutagen. Mutation Res. 28:1975;113-122.
23. IARC (International Agency for Research on cancer). IARC Monographs on the Evaluation of the Carcinogenic Risks of Chemical to Humans. Vol. 38:1986;421 IARC, Lyon. Tobacco Smoking.
24. Kado N.Y., Langley D., Eisenstadt E. A simple modification of the Salmonella liquid-incubation assay. Increased sensitivity for detecting mutagens in human urine. Mutation Res. 121:1983;25-32.
25. Löfroth G., Ling P.I., Agurell E. Public exposure to environmental tobacco smoke. Mutation Res. 202:1988;103-110.
26. Lowry O.H., Rosebrough N.J., Fan A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. McGregor D.B., Prentice R.D., McConville M., Lee Y.J., Caspari W.J. Reduced mutant yield at high doses in the Salmonella/activation assay: the cause is not always toxicity. Environ. Mutagen. 6:1984;547-557.
28. Malaveille C., Vineis P., Estéves J., Ohshima H., Brun G., Hautefeuille A., Gallet P., Ronco G., Terracini B., Bartsch H. Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risks of bladder cancer. Carcinogenesis. 10:1989;577-586.
29. Malling H.V. Dimethylinitrosamine: formation of mutagenic compounds by interaction with mouse liver microsome. Mutation Res. 13:1971;425-429.
30. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutation Res. 113:1983;173-215.
31. Matsushita H. Jr, Endo O., Matsushita H., Yamamoto M., Mochizuki M. Mutagenicity of alkylhydrazine oxalates in Salmonella typhimurium TA100 and TA102 demonstrated by modifying the growth conditions of the bacteria. Mutation Res. 301:1993;213-222.
32. Mead R. The nonorthogonal designs of experiments. J. R. Statist. Soc. A. 153:1990;151-201.
33. Mersch-Sundermann V., Krämer H. The influence of culture conditions on the susceptibility of Salmonella typhimurium in the Salmonella mutagenicity test. Zbl. Hyg. 193:1993;471-480.
34. Nagao M., Yahagi T., Seino Y., Sugimara T., Ito W. Mutagenicities of quinoline and its derivatives. Mutation Res. 42:1977;335-342.
35. Neudecker T, Henschler D. Allyl isothiocyanate is mutagenic in Salmonella typhimurium. Mutation Res. 156:1985;33-37.
36. O'Donavan M.R. The comparative responses of Salmonella typhimurium TA1537 and TA97a to a range of reference mutagens and novel compounds. Mutagenesis. 5:1990;267-274.
37. Paolini M., Hrelia P., Corsi C., Bronzetti G., Biagi G.L., CantelliForti G. NADPH as a rate limiting factor for microsomal metabolism An alternative and economic NAPDH-generating system for microsomal monooxygenase in vitro genotoxicity studies. Mutation Res. 178:1987;11-20.
38. Paolini M., Sapigni E., Hrelia P., Grilli S., Lattanzi G., Scotti M., Cantelli-Forti G. Strategies for optimization of short-term genotoxicity tests: the synergistic effect of NADPH and NADH on P450 function in processing premutagens. Mutagenesis. 5:1990;51-54.
39. 32Postlabelling analysis of urinary mutagens from smokers of black tobacco implicates 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) as a major DNA-damaging agent. Carcinogenesis. 12:1991;713-717.
40. 32P-postlabelling analysis of DNA adducted with urinary mutagens from smokers of black tobacco. Carcinogenesis. 11:1990;1307-1311.
41. Rees R.W., Brice A.J., Carlton J.B., Gilbert P.J., deG. Mitchell I. Optimization of metabolic activation for four mutagens in a bacterial, fungal and two mammalian cell mutagenesis assays. Mutagenesis. 4:1989;335-342.
42. Van der Hoeven W., Kooijman S.A.L.M., De Raat W.K. Salmonella test: relation between mutagenicity and number of revertants colonies. Mutation Res. 234:1990;289-302.
43. Venitt S. The use of short-term tests for the detection of genotoxic activity in body fluids and excreta. Mutation Res. 205:1988;331-353.
44. Venitt S., Bosworth D. Further studies on the detection of mutagenic and genotoxic activity in human faeces: aerobic and anaerobic fluctuation tests with S. typhimurium and E. coli and the SOS Chromotest. Mutagenesis. 1:1986;49-64.
45. Venitt S., Bosworth D. The development of anaerobic methods for bacterial mutation assays: aerobic and anaerobic fluctuation tests of reference mutagen and human fecal extracts. Carcinogenesis. 4:1983;339-345.
46. Venitt S., Crofton-Sleigh C., Forster R. Bacterial mutations assays using reverse mutation. Venitt S., Parry J.M. Mutagenicity Testing. A Practical Approach. 1984;45-98 IRL Press, Oxford, Washington DC.
47. Yahagi T., Degawa M., Seino Y., Matsushima T., Nagao M., Sugimura T., Hasimoto Y. Mutagenicity of carcinogenic azo dyes and their derivatives. Cancer Lett. 1:1975;91-96.
48. Yahagi T., Nagao M., Seino Y., Matsushima T., Sugimura T., Okada M. Mutagenicities of N-nitrosamines on Salmonella. Mutation Res. 118:1977;127-129.
49. Yamasaki E., Ames B.N. Concentration of mutagens from urine with nonpolar resin XAD-2: cigarette smokers have mutagenic urine. Proc. Natl. Acad. Sci. USA. 74:1977;3555-3559.